Pearl River Capital’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-35,888
Closed -$4.02M 446
2024
Q1
$4.02M Buy
35,888
+20,754
+137% +$2.24M 0.63% 32
2023
Q4
$1.53M Sell
15,134
-10,777
-42% -$1.07M 0.24% 125
2023
Q3
$2.25M Buy
25,911
+23,447
+952% +$2.12M 0.35% 86
2023
Q2
$233K Buy
+2,464
New +$208K 0.04% 430
2022
Q1
Sell
-21,294
Closed -$1.1M 411
2021
Q4
$1.1M Buy
+21,294
New +$1.04M 0.3% 104
2021
Q1
Sell
-13,515
Closed -$724K 400
2020
Q4
$724K Sell
13,515
-8,427
-38% -$437K 0.26% 136
2020
Q3
$1.03M Sell
21,942
-3,815
-15% -$196K 0.43% 69
2020
Q2
$1.34M Buy
+25,757
New +$1.33M 0.67% 40
2020
Q1
Sell
-11,138
Closed -$563K 534
2019
Q4
$563K Buy
11,138
+10,096
+969% +$521K 0.21% 157
2019
Q3
$49K Buy
+1,042
New +$47.6K 0.14% 200

Other funds holding CAH

Pearl River Capital's CAH Position: Q2 2024 in Review

Pearl River Capital sold out of Cardinal Health (CAH) in Q2 2024, closing a stake of 35,888 shares — an estimated $4.02M sold.

Pearl River Capital first reported a position in CAH in Q3 2019 and held it in 10 quarters. The position peaked at $4.02M in Q1 2024. 1,009 funds tracked by Wall St. Rank hold CAH as of Q2 2024.

  • Pearl River Capital reported no remaining Cardinal Health position as of Q2 2024 after selling out during the quarter.
  • Pearl River Capital sold 35,888 Cardinal Health shares in Q2 2024, an estimated $4.02M.
  • Pearl River Capital first reported a position in Cardinal Health in Q3 2019 and held it in 10 quarters.
  • Pearl River Capital's Cardinal Health position peaked at $4.02M in Q1 2024.
  • 1,009 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2024.

Based on Pearl River Capital's 13F filing for Q2 2024, filed 13 Aug 2024.